Definition: A GLP-1 receptor agonist is a drug that switches on the same receptor as GLP-1 (glucagon-like peptide-1), a hormone the gut releases after you eat. GLP-1 raises insulin when blood sugar is high, lowers glucagon and reduces appetite. Semaglutide (Ozempic, Wegovy) and liraglutide are GLP-1 receptor agonists.
"Agonist" means a molecule that activates a receptor. Drug makers change the GLP-1 chain to make it last longer. The Wegovy label describes semaglutide as a GLP-1 analog with 94% sequence match to human GLP-1 and an elimination half-life of about 1 week, which is why it is a once-weekly shot.
GLP-1 is one of two "incretin" hormones, gut hormones that boost insulin after a meal. The other is GIP. GLP-1 also slows appetite, which over time leads to weight loss (Nauck & Meier 2018).
GLP-1 medicines start low and step up, a process called titration. A log that records the dose and the date of each change makes it easy to line up how you feel with each step.
Reading the Wegovy step schedule
Your prescriber may hold you on a step longer. Log the dose you actually took, not the one the schedule says.
Read more on Dose Track: Semaglutide · Wegovy · Semaglutide vs tirzepatide · GLP-1 units guide